GD-DTPA-Gel-Cis

a conjugate of gadolinium (Gd), cis diamminedichloroplatinum (Cis), diethylenetriaminepentaacetic acid (DTPA)-dianhydride, and bovine gelatin (Gel) that can be used as an intravascular contrast agent at MRI and as an antitumor cell proliferation agent in vitro

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Murata, Kiyoshi: 2 articles (10/2009 - 09/2009)
2.	Nitta, Norihisa: 2 articles (10/2009 - 09/2009)
3.	Sonoda, Akinaga: 2 articles (10/2009 - 09/2009)
4.	Tabata, Yasuhiko: 2 articles (10/2009 - 09/2009)
5.	Takahashi, Masashi: 2 articles (10/2009 - 09/2009)
6.	Jo, Jun-Ichiro: 1 article (10/2009)
7.	Murata, Satoshi: 1 article (10/2009)
8.	Nitta-Seko, Ayumi: 1 article (10/2009)
9.	Ohta, Shinich: 1 article (10/2009)
10.	Tani, Toru: 1 article (10/2009)

Related Diseases

1.	Stroke (Strokes) 09/01/2009 - "Gd-DTPA-Gel-Cis (100 mg/10 ml) enclosed into the cellulose dialysis tubing was placed in 90 ml of bovine serum and shaken reciprocally at 72 stroke/min at 37 degrees C. "
2.	Neoplasms (Cancer) 10/01/2009 - "We injected Gd-DTPA-Gel-Cis (200 mg/mL) into the caudal vein of female HER-2/neu transgenic mice with spontaneous mammary tumors. "

Related Drugs and Biologics

1.	Cellulose